<qa>  What is the effect of these therapies on triglyceride levels?Patients with metabolic syndrome, insulin resistance, and elevated triglycerides of 150 mgdl or higher will be randomized to one of four groups: 1 placebo; 2 metformin; 3 fenofibrate; or 4 combined metformin and fenofibrate for a period of 12 weeks after titration to target dose. We are interested in the effects of these therapies on triglyceride levels, HDL-C, insulin resistance, and markers of inflammation. 